Investors Research Corp trimmed its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 17.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,175 shares of the financial services provider’s stock after selling 2,975 shares during the period. Investors Research Corp’s holdings in MetLife were worth $1,161,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently bought and sold shares of MET. MeadowBrook Investment Advisors LLC grew its stake in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares in the last quarter. Peterson Financial Group Inc. purchased a new position in MetLife in the third quarter valued at about $30,000. Retirement Wealth Solutions LLC purchased a new position in MetLife in the fourth quarter valued at about $32,000. Sierra Ocean LLC purchased a new position in MetLife in the fourth quarter valued at about $32,000. Finally, Coastline Trust Co purchased a new position in MetLife in the third quarter valued at about $35,000. 94.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on the company. JPMorgan Chase & Co. upped their price target on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Keefe, Bruyette & Woods dropped their target price on MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a report on Wednesday, February 12th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen lifted their target price on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Finally, BMO Capital Markets initiated coverage on MetLife in a research note on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price objective for the company. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.58.
MetLife Price Performance
Shares of MET opened at $82.28 on Monday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $56.05 billion, a P/E ratio of 13.78, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04. The firm has a 50 day moving average of $83.72 and a 200 day moving average of $82.35. MetLife, Inc. has a twelve month low of $67.30 and a twelve month high of $89.05.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, equities research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a $0.545 dividend. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.65%. MetLife’s dividend payout ratio is currently 36.52%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 4 Stocks Up 20%+ in the Last Month—Is More Growth Ahead?
- Most active stocks: Dollar volume vs share volume
- Insider Scoop: 4 Stocks Insiders Are Buying and Selling
- Conference Calls and Individual Investors
- Play Both Sides: 3 Bond ETFs to Balance Offense and Defense
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.